{"nctId":"NCT00086385","briefTitle":"Maintaining Nonsmoking: Older Smokers - 1","startDateStruct":{"date":"2001-09"},"conditions":["Tobacco Use Disorder"],"count":403,"armGroups":[{"label":"Brief Treatment","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Nicotine polacrilex, Bupropion"]},{"label":"Extended NRT","type":"EXPERIMENTAL","interventionNames":["Drug: Nicotine polacrilex, Bupropion"]},{"label":"Tailored/No Extended NRT","type":"EXPERIMENTAL","interventionNames":["Drug: Nicotine polacrilex, Bupropion"]},{"label":"Extended Tailored Counseling + NRT","type":"EXPERIMENTAL","interventionNames":["Drug: Nicotine polacrilex, Bupropion"]}],"interventions":[{"name":"Nicotine polacrilex, Bupropion","otherNames":["Nicorette, Zyban"]}],"eligibilityModule":{"eligibilityCriteria":"smokers of at least 10 cigarettes per day\n\nInclusion Criteria:\n\nMULTIPLE\n\nExclusion Criteria:\n\nMULTIPLE","healthyVolunteers":true,"sex":"ALL","minimumAge":"50 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Participants Abstinent From Cigarettes","description":"Primary outcome variable was 7-day point prevalence cigarette abstinence verified biochemically at week 104","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"31","spread":"5.4"},{"groupId":"OG001","value":"35","spread":"6.82"},{"groupId":"OG002","value":"39","spread":"5.64"},{"groupId":"OG003","value":"45","spread":"5.46"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":2,"n":100},"commonTop":["Insomnia","Dental Issues","Lung Biopsy","Midsternal Pressure","Anxiety, High Blood Presure"]}}}